| |
| |
|
| Insider
Information: |
Utter Christine Marie |
| Relationship: |
|
| City: |
South Plainfield |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
52,428 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,103,411 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
52,428 |
|
|
| Total
Value |
$2,103,411 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
9
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -143.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PTC Therapeutics, Inc. |
PTCT |
|
2024-02-15 |
52,428 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
56 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTCT |
PTC Therapeutics, Inc. |
Principal Financial OfficerOff |
• – – |
2017-06-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,297 |
|
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Principal Financial Officer |
• – – |
2019-01-07 |
4 |
S |
$34.75 |
$10,321 |
D/D |
(297) |
7,446 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2022-02-01 |
4 |
AS |
$40.00 |
$12,521 |
D/D |
(313) |
26,112 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2021-01-05 |
4 |
S |
$62.37 |
$19,709 |
D/D |
(316) |
9,488 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, CHIEF ACCOUNTING OFFICER |
• – – |
2024-01-30 |
4 |
S |
$27.25 |
$8,666 |
D/D |
(318) |
35,528 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, FINANCE & CAO |
• – – |
2023-01-31 |
4 |
S |
$45.63 |
$14,829 |
D/D |
(325) |
38,059 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2020-01-06 |
4 |
AS |
$48.17 |
$17,340 |
D/D |
(360) |
5,224 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2021-02-01 |
4 |
AS |
$56.96 |
$20,960 |
D/D |
(368) |
17,161 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Principal Financial Officer |
• – – |
2018-01-04 |
4 |
S |
$17.67 |
$7,280 |
D/D |
(412) |
6,660 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, FINANCE & CAO |
• – – |
2023-01-11 |
4 |
S |
$44.36 |
$18,498 |
D/D |
(417) |
38,384 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, FINANCE & CAO |
• – – |
2023-01-10 |
4 |
S |
$42.93 |
$20,994 |
D/D |
(489) |
38,801 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2021-02-02 |
4 |
AS |
$57.64 |
$37,581 |
D/D |
(652) |
16,509 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, FINANCE & CAO |
• – – |
2023-01-09 |
4 |
S |
$41.66 |
$29,409 |
D/D |
(706) |
39,290 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2022-02-02 |
4 |
AS |
$40.38 |
$28,549 |
D/D |
(707) |
25,405 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2022-01-07 |
4 |
S |
$38.53 |
$28,778 |
D/D |
(747) |
16,253 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2020-04-03 |
4 |
OE |
$11.23 |
$8,838 |
D/D |
787 |
10,091 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2020-04-03 |
4 |
AS |
$44.31 |
$34,872 |
D/D |
(787) |
9,304 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2020-10-05 |
4 |
AS |
$48.68 |
$38,311 |
D/D |
(787) |
9,562 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2020-10-05 |
4 |
OE |
$11.23 |
$8,838 |
D/D |
787 |
10,349 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2020-01-03 |
4 |
AS |
$47.42 |
$37,367 |
D/D |
(788) |
5,584 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2020-01-03 |
4 |
OE |
$11.23 |
$8,849 |
D/D |
788 |
6,372 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2019-06-28 |
4 |
OE |
$18.01 |
$20,557 |
D/D |
988 |
5,640 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2019-06-28 |
4 |
AS |
$45.00 |
$44,460 |
D/D |
(988) |
4,937 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, FINANCE & CAO |
• – – |
2024-01-08 |
4 |
S |
$28.64 |
$34,025 |
D/D |
(1,188) |
37,499 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, FINANCE & CAO |
• – – |
2024-01-09 |
4 |
S |
$29.01 |
$47,961 |
D/D |
(1,653) |
35,846 |
0 |
% |
|
56 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
